• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Celldex Therap released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 1.084 M), actual EPS USD -1.0093 (forecast USD -0.9063)
04:00
Celldex Therap released FY2025 9 Months earnings on November 10, 2025 (EST), actual revenue USD 1.425 M, actual EPS USD -2.6729
04:00
Aug8
Celldex Therap released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 730K (forecast USD 1.132M), actual EPS USD -0.8525 (forecast USD -0.8663)
03:00
Celldex Therap released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 1.424 M (forecast USD 2.75 M), actual EPS USD -1.6628 (forecast USD -1.48)
03:00
Jun14
Cedars Medical Presents Phase II Study Data on Chronic Spontaneous Urticaria Drug
14:51
Jun10
Sedaris Medical to Present Bazolovi Monoclonal Antibody Phase II Data at EAACI
20:02

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -67.04 M, EPS -1.0093

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 730 K, Net Income -56.6 M, EPS -0.8525

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 695 K, Net Income -53.8 M, EPS -0.8103

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
VMAR
1.089
+186.58%
+0.715
SRXH
0.5935
+94.91%
+0.289
AMCI
12.866
+76.98%
+5.580
EDHL
0.5706
+49.53%
+0.187
CPAC
10.282
+47.09%
+3.292
RILY
5.090
+36.83%
+1.387
RZLV
3.124
+34.66%
+0.802
EEX
4.684
+32.32%
+1.144
VERO
2.195
+31.44%
+0.525
CHOW
1.005
+28.50%
+0.223
View More